Civica Rx is planning a $124.5 million drug manufacturing facility in Petersburg, Virginia, to be developed as part of an advanced pharmaceutical manufacturing campus it said would play a role in addressing shortages that have disrupted hospital operations and put patients at risk for more than a decade.